Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 24 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
Recruiting
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
NCT04002947
- Conditions
- DLBCL, Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT07283796
- Conditions
- NHL
- Locations
-
- Chinese Academy of Medical Sciences Blood Diseases Hospital Tianjin, China
NCT06119685
- Conditions
- Blood Cancer, Blood Protein Disorders, Cardiovascular Diseases, +23 more
- Locations
-
- Valkyrie Clinical Trials Los Angeles, California, United States
- Florida Cancer Specialists and Research Institute - Lake Mary Cancer Center Lake Mary, Florida, United States
- Emory University Hospital Atlanta, Georgia, United States
- University of Minnesota Minneapolis, Minnesota, United States
NCT06731699
- Conditions
- AML, NHL
- Locations
-
- West China Hospital of Sichuan University Chengdu, Sichuan, China
NCT05641428
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- NL-Amsterdam-AMC Amsterdam, Netherlands
- NL-Groningen-UMCG Groningen, Netherlands
- NL-Leiden-LUMC Leiden, Netherlands
- NL-Maastricht-MUMC Maastricht, Netherlands
NCT04440436
- Conditions
- NHL
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
Not specified
Not Yet Recruiting
CMOP±R in the Treatment of Untreated Non-Hodgkin's Lymphoma
NCT06486337
- Conditions
- NHL
- Locations
-
Not specified
NCT02315612
- Conditions
- ALL, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, +32 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Completed
Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies
NCT05371054
- Conditions
- Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +13 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT04555811
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma, +12 more
- Locations
-
- University of Minnesota Minneapolis, Minnesota, United States
- Washington University School of Medicine - Siteman Cancer Center St Louis, Missouri, United States
NCT03527147
- Conditions
- DLBCL, Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- Research Site Los Angeles, California, United States
- Research Site Sarasota, Florida, United States
- Research Site Atlanta, Georgia, United States
- Research Site New Orleans, Louisiana, United States
Completed
Safety Study of NHL With 90Y-hLL2 IgG
NCT00421395
- Conditions
- B-cell NHL, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Research Unit 463 INSERM Nantes, Cedex, France
- Service des Maladies du Sang Lille, France
- University Hospital Dresden Dresden, Germany
- Klinikum der Georg-August-Universitat Gottingen Göttingen, Germany
NCT00546793
- Conditions
- CLL, Chronic Disease, Dendritic Cell Sarcoma, Interdigitating, +35 more
- Locations
-
- Lewis Cancer Center and Research Pavilion Savannah, Georgia, United States
- Cancer Care at Saint Clare's/Saint Clares Hospital Oncology & Hematology Specialists, P.A. Denville, New Jersey, United States
- Morristown Memorial Hospital Morristown, New Jersey, United States
- New York Hospital Weill Cornell Medical Center New York, United States
NCT00342121
- Conditions
- NHL, Neoplasms
- Locations
-
- University of Iowa Iowa City, Iowa, United States
NCT00185692
- Conditions
- Blood Cancer, CLL, Graft Versus Host Disease, +18 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States
NCT00891592
- Conditions
- ALL, AML, Blood Protein Disorders, +21 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT00513175
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +61 more
- Locations
-
- University of California San Francisco San Francisco, California, United States
Completed
CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation
NCT00333190
- Conditions
- ALL, AML, Blood Protein Disorders, +24 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Active, Not Recruiting
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
NCT03739502
- Conditions
- ALL, AML, Bone Marrow Diseases, +16 more
- Locations
-
- University of Rochester Rochester, New York, United States